Navigation Links
ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study
Date:9/15/2010

nerally well tolerated at all dose levels; there were no serious or severe adverse events, and no discontinuations from study drug due to adverse events.
  • All 27 volunteers (100 percent) who were given VP20621 had positive non-toxigenic C. difficile stool cultures by day 6, suggesting that VP20621 rapidly colonizes the susceptible GI tract.
  • No patient dosed with VP20621 tested positive for toxin-producing strains of C. difficile during the 28-day study period.
  • By comparison, 5 of 9 subjects (56 percent) who received placebo (i.e. did not receive VP20621) tested positive for either toxin-negative or toxin-positive C. difficile during the study period.

  • "I am highly encouraged by the data from this Phase 1 study of VP20621, which for the first time support the tolerability and colonization effectiveness of non-toxigenic C. difficile, mimicking what we have inferred from observing colonization of patients with these organisms," commented Dale Gerding, M.D., Associate Chief of Staff for Research at the Hines VA Hospital.  "Colonization protection of VP20621 awaits demonstration in a Phase 2 clinical trial in CDI patients to confirm pre-clinical data and observational studies of natural colonization in humans that have demonstrated high levels of protection against CDI that approach 100%."

    "Previous animal and clinical observational studies have described the prevention of symptomatic CDI by colonization of the large bowel with non-toxin producing strains of C. difficile," commented Dr. Colin Broom, ViroPharma's chief scientific officer.  "We now know that VP20621 appears to behave similarly, rapidly colonizing the large bowel and potentially protecting it from colonization with dangerous toxin-producing strains of C. difficile. We are excited by these positive data and expect to move rapidly into Phase 2 studies with VP20621 in the coming months
    '/>"/>

    SOURCE ViroPharma Incorporated
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. ViroPharma to Present at Three Upcoming Healthcare Conferences
    2. ViroPharma to Present at the Natixis Bleichroeder Conference
    3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
    4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
    5. ViroPharma Announces Discontinuation of HCV-796 Development
    6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
    7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
    8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
    9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
    10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
    11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ... Testing - Global Strategic Business Report" report to ... markets for ADME-Toxicology Testing in US$ Million by the ... Testing. The report provides separate comprehensive analytics ... Japan , Europe , ...
    (Date:4/17/2015)... , Apr. 17, 2015 Research and Markets ... of the "Mammography Equipment - Global Strategic Business ... report analyzes the worldwide markets for Mammography Equipment in ... Equipment, and Digital Mammography Equipment. The report provides separate ... , Japan , Europe ...
    (Date:4/17/2015)... , April 17, 2015 Today, ... honored 13 employees from 12 biopharmaceutical companies as ... efforts in policy advocacy and community service. ... Health Champion Awards were created by the biopharmaceutical ... excelled in their careers, but have also shown ...
    Breaking Medicine Technology:ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report: Breast Imaging Screening Programs Push Sales 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3
    ... ANGELES, March 3, 2011 InstaCare Corp. (OTC Bulletin ... prescription drugs, home testing products for the chronically ill, ... programs, and a leading developer of revolutionary patent pending ... today announced that it has migrated its recently patent ...
    ... Virtual Radiologic (vRad), a technology-enabled national ... Central Illinois-based radiology practice serving Champaign/Urbana, Effingham, ... of a strategic alliance, merging Lakeland with ... practice will be called Lakeland Radiology Alliance, ...
    Cached Medicine Technology:InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems 2InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems 3Virtual Radiologic and Lakeland Radiologists Partner to Create Lakeland Radiology Alliance 2Virtual Radiologic and Lakeland Radiologists Partner to Create Lakeland Radiology Alliance 3
    (Date:4/19/2015)... Hanover, MA (PRWEB) April 19, 2015 Family ... Bowling for Brains in Memory of Brad Baddeley ... renowned Brain Aneurysm Foundation. , Bowling for Brains is cheduled ... Bowling located 4700 Dudley Street in Lincoln, Nebraska. Participants may ... from 1:00 to 3:00pm. , The cost is only $4 ...
    (Date:4/18/2015)... 18, 2015 Compare-autoinsurance.org has released a ... reliable auto insurance policy . , Clients should ... insurance quotes online is safe and reliable. An insurance ... quotes are displayed on a single web page, so ... , It is now possible to compare online car ...
    (Date:4/18/2015)... "I recognized the need for a better way ... inventor from Cincinnati, Ohio. "This need inspired me to ... Slyde Door to offer an alternative to the conventional ... convenient storage space for an evacuation stretcher. The door ... , This offers added peace of mind to ...
    (Date:4/18/2015)... Lowcostcarinsuranceprice.com has released a new blog post ... auto insurance prices . , Drivers who live ... may have to pay more for auto insurance plans ... can also offer protection against vehicle theft. , ... on a single website: http://lowcostcarinsuranceprice.com/ . Drivers ...
    (Date:4/18/2015)... In the past few weeks, TheBeautyPlace.com ... , "We had to run maintenance on our shipping ... Jennifer Ramirez, the PR Director. "It disrupted our regular ... we are back on track after having completed the ... changing phone systems which has not allowed some calls ...
    Breaking Medicine News(10 mins):Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:A Guide For Avoiding Online Auto Insurance Scams! 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:TheBeautyPlace.com Temporary Number Available 2
    ... properties of bacteria to form barrier against illness , , ... Polytechnic Institute say that have solved the mystery of ... study, published in the current issue of Colloids ... the thermodynamic properties of bacteria in the urinary tract ...
    ... National Institutes of Health has awarded $128 million to ... Jeffrey Krischer, PhD, to coordinate worldwide studies on the ... a seven-year award, supports Dr. Krischer,s coordination of the ... , The award adds to the $169 million received ...
    ... Masimo provides Aurora with technology and sensor standardization ... its facilities - creating efficiencies and cost savings, ... inventor,of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion Pulse,Oximetry, announced that ... Masimo SET pulse oximetry technology. The integrated health,care ...
    ... As tens of thousands of Americans,prepare to attend the ... injury or illness -- and how to deal with ... adequate, appropriate medical care in foreign lands can be,daunting, ... themselves,peace of mind," said Angelo Masciantonio, CEO and co-founder ...
    ... 31 /Xinhua-PRNewswire/ -- Chindex International,Inc. (Nasdaq: CHDX ... products and services in the People,s Republic of ... fiscal 2009 first quarter,financial results on Thursday, August ... a conference call at 8:00 am ET that ...
    ... Feat could one day lead to tailor-made cells to treat ... -- Scientists have turned skin cells from patients with Lou ... the patients, own neurons. , An unlimited number of these ... a capability which should result in a better understanding of ...
    Cached Medicine News:Health News:Study Explains How Cranberries Prevent Urinary Infections 2Health News:University of South Florida receives new multimillion award to assess juvenile diabetes treatments 2Health News:University of South Florida receives new multimillion award to assess juvenile diabetes treatments 3Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 2Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 3Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 4Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 5Health News:Americans Attending Beijing Olympics Should Plan Ahead for Medical Emergencies 2Health News:Chindex International to Report Fiscal 2009 First Quarter Financial Results 2Health News:Chindex International to Report Fiscal 2009 First Quarter Financial Results 3Health News:Scientists Turn Skin Cells Into Motor Neurons in ALS Patients 2Health News:Scientists Turn Skin Cells Into Motor Neurons in ALS Patients 3
    ... is a molecular biology grade, standard melting temperature ... of small DNA, RNA, and PCR products = ... of gel processing and blotting. Performance testing of ... fragments up to 1,000 bp, though this agarose ...
    This agarose provides superior resolution of small PCR fragments and primers at lower concentrations than standard agaroses. A 3% gel clearly resolves a 10 bp ladder, and a 4% gel approaches the reso...
    A custom blend for Applied Biosystems by FMC. Designed specifically for the electrophoresis of PCR products....
    The reading of agglutinations process in Diana Reader is by image treatment which allows great sensitivity....
    Medicine Products: